César Rodríguez

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).

M. Lux, R. Greil, A. Schneeweiss, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Innovation and jobs: evidence from manufacturing firms

J. Jaumandreu, César Rodríguez, A. García, 2004 .

Innovation and jobs at the firm level

César Rodríguez, A. González, Jordi Jaumandreu Balanzo, 1998 .